Distribution and molecular drivers of the 21-gene recurrence score in early breast cancer with low, intermediate, and high estrogen receptor expression - Top-Institutions - MDSpire

Distribution and molecular drivers of the 21-gene recurrence score in early breast cancer with low, intermediate, and high estrogen receptor expression

  • By

  • Shuai Li

  • Jiahui Huang

  • Yifei Zhu

  • Jin Hong

  • Siji Zhu

  • Weiqi Gao

  • Ou Huang

  • Jianrong He

  • Weiguo Chen

  • Yafen Li

  • Xiaosong Chen

  • Kunwei Shen

  • Jiayi Wu

  • April 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Cancer
    • Molecular Oncology
    • Genomic Assays

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Oncology
    • Cancer Genomics
    • Translational Research

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Cancer Research
    • Molecular Diagnostics
    • Clinical Oncology

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Breast Cancer Genomics
    • Molecular Pathology
    • Translational Oncology

  • #5

    Shanghai Jiao Tong University School of Medicine
    Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai

    Key Differentiators

    • Breast Cancer Research
    • Molecular Oncology
    • Genomic Medicine

Original Source(s)

Distribution and molecular drivers of the 21-gene recurrence score in early breast cancer with low, intermediate, and high estrogen receptor expression

  • by Shuai Li, Jiahui Huang, Yifei Zhu, Jin Hong, Siji Zhu, Weiqi Gao, Ou Huang, Jianrong He, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen, Jiayi Wu

  • April 30, 2026

Related Content

Differential diagnosis of testicular embryonal rhabdomyosarcoma and testicular seminoma with enhanced CT: a retrospective study

Near–Real-Time Clinical Trial Accrual Dashboard in a National Cancer Institute–Designated Cancer Center: Mixed Methods Implementation Study

Preliminary construction and validation of a prognostic prediction model for cervical cancer based on tumor mechanics-related genes